Oslo, Mar 19 (Prensa Latina) Norwegian scientists linked the Covid-19 vaccine developed by the pharmaceutical company AstraZeneca and Oxford University with the formation of blood clots, an opinion that differs from their colleagues in the United Kingdom and the Netherlands.
The adverse reaction was triggered by a strong, highly specific immune response, according to the Scandinavian experts, who point out that there is nothing else in the patients' clinical history that could generate such a situation.
The experts detected specific antibodies that activate platelets which, in some cases, can cause blood clots, Russia Today reported on its website on Friday.
However, British and Dutch experts reject such a criterion about the vaccine, pointing out that there is no link between the vaccine and the aforementioned adverse reaction.
The World Health Organization (WHO) is currently reviewing reports on the suspension in several countries of the vaccine developed by AstraZeneca Pharmaceuticals and Oxford University.
Austria, Estonia, Latvia, Lithuania, Luxembourg and Italy have stopped using some batches of the vaccine, while Denmark, Thailand, Norway and Iceland have suspended immunization with the product.
The decision by these countries follows, mostly, reports on the formation of blood clots in people who had been vaccinated.
The same batch was distributed in 17 countries, including Spain, where so far no such cases have been reported, only minor effects.
The WHO stressed that it is studying the situation of the AstraZeneca and Oxford University vaccine and the results will be published with recommendations.
jg/abo/mem/joe
The experts detected specific antibodies that activate platelets which, in some cases, can cause blood clots, Russia Today reported on its website on Friday.
However, British and Dutch experts reject such a criterion about the vaccine, pointing out that there is no link between the vaccine and the aforementioned adverse reaction.
The World Health Organization (WHO) is currently reviewing reports on the suspension in several countries of the vaccine developed by AstraZeneca Pharmaceuticals and Oxford University.
Austria, Estonia, Latvia, Lithuania, Luxembourg and Italy have stopped using some batches of the vaccine, while Denmark, Thailand, Norway and Iceland have suspended immunization with the product.
The decision by these countries follows, mostly, reports on the formation of blood clots in people who had been vaccinated.
The same batch was distributed in 17 countries, including Spain, where so far no such cases have been reported, only minor effects.
The WHO stressed that it is studying the situation of the AstraZeneca and Oxford University vaccine and the results will be published with recommendations.
jg/abo/mem/joe
Temas Relacionados:
